Potential for new drugs targeting cells leading to inflammation in fat tissue
Scientists at the Walter and Eliza Hall Institute (WEHI) have completed a study showing that cells which lead to inflammation in fat tissue may be a primary cause of insulin resistance in sufferers of
diabetes.
A xenotransplantation technology using insulin producing cells from pigs offers new hope for diabetes sufferers.
Back when Living Cell Technologies's (LCT) current Medical Director and Founder, Professor Bob Elliott, was working in his Auckland clinic, he decided that the treatments available for patients with Type I diabetes simply weren't good enough.
The Human Proteome Organisation (HPUO) 2010 World Congress and the Human Proteome Project feature in this issue, along with proteomics, synthetic biology, genetics and genomics, and next generation genome sequencing.
The July/August edition of Australian Life Scientist is out now. The issue takes an in-depth look at the happenings at the upcoming Human Proteome Organisation (HPUO) 2010 World Congress, which will host the launch of the long awaited Human Proteome Project.
Australian and British scientists report major breakthrough in understanding of human digestion with implications for diabetes treatment
An Australian and a British researcher have published the results of a breakthrough study expected to transform traditional thinking about the digestive process and possibly lead to new treatments for and other diseases.
New insulin stable at room temperature spells better quality of life for diabetics
A PhD student from Monash University has succeeded in tweaking the chemical structure of insulin leading potentially to the development of medications that are stable at room temperature.
Garvan scientists find modest weight loss can dramatically reduce number of pro-inflammatory T-helper cells.
Over half the Australian population is either overweight or obese, with many experiencing corresponding health effects, such as cardiovascular disease and Type 2 diabetes.
Phosphagenics signs global agreement for use of transdermal insulin in pets.
Phosphagenics signs global agreement for use of transdermal insulin in pets.
New clinical trial for type I diabetes treatment using xenotransplantation of pig cells to begin in New Zealand.
New clinical trial for type I diabetes treatment using xenotransplantation of pig cells to begin in New Zealand.
Structure of a previously unseen part of the insulin receptor has been revealed by WEHI scientists.
Structure of a previously unseen part of the insulin receptor has been revealed by WEHI scientists.
An international research team has identified new gene variants associated with gluten intolerance.
An international research team has identified new gene variants associated with gluten intolerance.
Datamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues.
Datamonitor Group predicts antidiabetics market will continue to expand, but obesity plagued by perception and treatment issues.
Brings Living Cell Technologies closer to commercialisation of xenotransplantation device to treat diabetes.
Brings Living Cell Technologies closer to commercialisation of xenotransplantation device to treat diabetes.
Researchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes.
Researchers at the Garvan Institute of Medical Research found that individuals with Hepatitis C are more likely to develop diabetes.
A better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system.
A better understanding of neuropeptide Y could lead to new therapeutics to treat obesity. Herbert Herzog gives some insights in to this complex system.
Mesoblast generates impressive gains over Christmas.
Mesoblast generates impressive gains over Christmas.
